Patent · US Expired

Intranasal yellow fever vaccination

US6337073B1 · kind B1 · utility

1Cited by

2References

2Claims

0Family size

Assignee

DEUTSCHES PRIMATENZENTRUM GMBH · DE

Inventors

Matthias Niedrig · Berlin, DE
Christiane Stahl-Hennig · Göttingen, DE
Gerhard Hunsmann · Göttingen, DE

Key dates

Filing date	Jun 22, 2000
Grant date	Jan 8, 2002
Priority date	—
Expiry date	Jun 22, 2020

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to vaccine preparations, pharmaceutical preparations and methods for inducing protective immunity in humans using a live, attenuated yellow fever virus of strain D17 preferably administered by an intranasal route of administration. The inventors have also developed an assay for detecting the induction of both the binding and neutralizing antibodies formed in a protective immune response in humans who have received an intranasal vaccine preparation of the kind described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.